Press "Enter" to skip to content

Roche: FDA approves drug combo Venclexta plus Gazyva for previously untreated chronic lymphocytic leukaemia

"Venclexta plus Gazyva is the only chemotherapy-free option of fixed duration that provides durable responses to help people live longer", Roche’s Chief Medical Officer Sandra Horning said.

Original source: https://health.economictimes.indiatimes.com/news/pharma/roche-fda-approves-drug-combo-venclexta-plus-gazyva-for-previously-untreated-chronic-lymphocytic-leukaemia/69353282?utm_source=RSS&utm_medium=ETRSS

Also Read:   EU warns of risks of Covid-19 vaccine race after UK approval of Pfizer shot